Gilead Sciences Inc (GILD)
Net profit margin
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 480,000 | 126,000 | 1,053,000 | 484,000 | 5,664,000 | 5,875,000 | 5,484,000 | 5,583,000 | 4,585,000 | 3,327,000 | 4,130,000 | 4,508,000 | 6,225,000 | 7,394,000 | 5,162,000 | 301,000 | 123,000 | 1,268,000 | -257,000 | 4,962,000 |
| Revenue (ttm) | US$ in thousands | 28,749,000 | 28,295,000 | 27,800,000 | 27,450,000 | 27,116,000 | 27,390,000 | 27,382,000 | 27,043,000 | 27,281,000 | 27,136,000 | 27,515,000 | 27,472,000 | 27,305,000 | 27,482,000 | 26,638,000 | 25,564,000 | 24,689,000 | 23,147,000 | 22,174,000 | 22,716,000 |
| Net profit margin | 1.67% | 0.45% | 3.79% | 1.76% | 20.89% | 21.45% | 20.03% | 20.64% | 16.81% | 12.26% | 15.01% | 16.41% | 22.80% | 26.90% | 19.38% | 1.18% | 0.50% | 5.48% | -1.16% | 21.84% |
December 31, 2024 calculation
Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $480,000K ÷ $28,749,000K
= 1.67%
The net profit margin of Gilead Sciences Inc has shown fluctuations over the period from March 31, 2020, to December 31, 2024. The net profit margin is a key financial metric that indicates the percentage of revenue that represents the company's bottom-line profit after all expenses have been deducted.
The trend analysis of Gilead Sciences Inc's net profit margin reveals that the company experienced a healthy net profit margin of 21.84% in March 31, 2020. However, the net profit margin turned negative to -1.16% in June 30, 2020, indicating that the company had incurred more expenses than revenues during that period.
Subsequently, the net profit margin recovered to 5.48% in September 30, 2020, but saw a significant decline to 0.50% in December 31, 2020. The trend continued with fluctuations over the following periods, showing some recovery in the net profit margin in March 31, 2021 (1.18%) and June 30, 2021 (19.38%).
The net profit margin continued to improve in the third quarter of 2021, reaching 26.90% in September 30, 2021. However, there was a slight decline in the net profit margin to 22.80% by December 31, 2021.
Looking further ahead, the net profit margin ranged from 12.26% to 20.64% in the subsequent quarters of 2022 and 2023, showing relative stability in the profitability of the company.
Towards the end of the period, there was a noticeable drop in the net profit margin, with values ranging from 0.45% to 3.79% in the last quarters of 2024. These lower margins may indicate higher expenses or challenges in generating profits during that timeframe.
Overall, the analysis of Gilead Sciences Inc's net profit margin suggests variability in profitability over the period under review, with periods of strong performance interspersed with challenges that impacted the company's bottom line. Monitoring and managing expenses while optimizing revenue generation will be crucial for maintaining a healthy net profit margin in the future.
Peer comparison
Dec 31, 2024